Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for XWELL, Inc. (XWEL : NSDQ)

• Company Description    XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. Number of Employees: 312

• Price / Volume Information    Yesterday's Closing Price: $0.46 Daily Weekly Monthly 20 Day Moving Average: 31,332 shares Shares Outstanding: 5.77 (millions) Market Capitalization: $2.66 (millions) Beta: 1.32 52 Week High: $1.69 52 Week Low: $0.43 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -40.70% -40.60% 12 Week -53.92% -54.66% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 254 WEST 31ST STREET 11TH FLOOR - NEW YORK,NY 10001 USA ph: 212-750-9595 fax: 309-410-3967 ir@xwell.com http://www.xwell.com

• General Corporate Information    Officers Ezra T. Ernst - Chief Executive Officer and Director Ian Brown - Chief Financial Officer Bruce T. Bernstein - Director Robert Weinstein - Director Michael Lebowitz - Director Peer Information XWELL, Inc. (CHCR) XWELL, Inc. (ESRX) XWELL, Inc. (MYDP) XWELL, Inc. (COR) XWELL, Inc. (GBCS) XWELL, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 98420U802 SIC: 7200 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/21/26 Share - Related Items Shares Outstanding: 5.77 Most Recent Split Date: 9.00 (0.05:1) Beta: 1.32 Market Capitalization: $2.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.87 Price/Cash Flow: - Price / Sales: 0.09 EPS Growth vs. Year Ago Period: 73.74% vs. Previous Quarter: 53.57% Sales Growth vs. Year Ago Period: -12.79% vs. Previous Quarter: -4.47% ROE 12/31/25 - - 09/30/25 - -352.37 06/30/25 - -265.41 ROA 12/31/25 - - 09/30/25 - -64.88 06/30/25 - -72.67 Current Ratio 12/31/25 - - 09/30/25 - 1.08 06/30/25 - 1.25 Quick Ratio 12/31/25 - - 09/30/25 - 1.02 06/30/25 - 1.19 Operating Margin 12/31/25 - - 09/30/25 - -51.85 06/30/25 - -63.18 Net Margin 12/31/25 - - 09/30/25 - -51.85 06/30/25 - -63.18 Pre-Tax Margin 12/31/25 - - 09/30/25 - -48.78 06/30/25 - -61.76 Book Value 12/31/25 - - 09/30/25 - 0.53 06/30/25 - 0.64 Inventory Turnover 12/31/25 - - 09/30/25 - 45.18 06/30/25 - 43.04 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 9.74 06/30/25 - 10.06

Powered by Zacks Investment Research ©